With the assistance of bioinformatics methods, the present study reported ERCC5, HES6 and RORA as biomarkers for CAD diagnosis based on WGCNA initially, in addition to their molecular mechanisms in the development of CAD. This evidence concerns the gene HES6 and coronary artery disorder.